Priority 1 Problem definition

Priority 1 Problem means any fault in a supported System(s) that causes a catastrophic impact to End User’s mission critical functionality. Examples of Priority 1 Problems include issues that cause the total loss or continuous instability of mission critical functionality such as the complete failure of an End User’s production network or System(s).
Sample 1Sample 2Sample 3
Priority 1 Problem means any fault in a supported Product that causes a catastrophic impact to an Ordering Activity’s mission critical functionality. Examples of Priority 1 Problems include issues that cause the total loss or continuous instability of mission critical functionality such as the complete failure of an Ordering Activity’s production network or system.
Sample 1Sample 2
Priority 1 Problem means a Defect in the Licensed Software such that GS is unable to use the Licensed Software. Licensor must initially respond to a Notification relating to a Priority 1 Problem within the time period specified below in Section 5(b) below, and will use its reasonable efforts to fix, provide a work-around, or otherwise resolve a Priority 1 Problem within the time period specified below in Section 5(b) below. Examples of Priority 1 Problems include: (1) the Licensed Software is not able to meet the Availability Standard due to a Defect (including as a result of the release into production of an Update); and (2) GS is unable to scale its use of the Licensed Software due to a Defect that causes the Licensed Software not to meet the Availability Standard.
Sample 1

Examples of Priority 1 Problem in a sentence

  • If a Work Around is successfully implemented, a Priority 1 Problem shall be reclassified to the appropriate priority level.

  • Subject to the foregoing, Juniper Networks will use all commercially reasonable efforts to deliver a workaround solution within 24 hours of the Priority 1 Problem having been observed or reproduced by Juniper Networks.

  • For each Priority 1 Problem, a Customer Support Representative will conduct a “post mortem” analysis that includes a closed loop corrective action plan.

  • If a Work-Around is successfully implemented, a Priority 1 Problem shall be reclassified to the appropriate priority level.

  • Select the AML problem that best reflects the emergency condition from the list of Priority 1 Problem Types.

  • For any Problem identified as a Priority 1 Problem, End User will provide Pulse Secure or its authorized service representative access to the affected network environment, and will assign a technical contact for Pulse Secure.

  • If a Priority 1 Problem is not resolved within a maximum of 1 hour from the time it is classified as such by Pulse Secure, the PSGSC will confer with the appropriate Pulse Secure engineering subject-matter expert.

  • Pulse Secure and End User shall work continuously (on a 24x7x365 basis), and shall use all commercially reasonable efforts, to work with End User’s dedicated resources to resolve the Priority 1 Problem until a Work-Around or a Problem Resolution is successfully implemented.

  • Subject to the foregoing, Pulse Secure will use all commercially reasonable efforts to deliver a workaround solution within 24 hours of the Priority 1 Problem having been observed or reproduced by Pulse Secure.

  • In particular, but not exclusively, the indication of an unrealistic price, which is a price that differs significantly from the well-known, generally accepted and available price of the service, is considered a wrong or incorrect price; - a price appearing as HUF "0", Euro "0" or HUF "1", Euro "1" that appears due to a potential system error, or a price that shows a strikingly disproportionate value.


More Definitions of Priority 1 Problem

Priority 1 Problem means a problem with the Software which renders the Software unusable or causes a crash of the end user's system. Pacific Softworks Inc. will exercise its best efforts to resolve Priority 1 Problems within ten (10) working days of problem identification and reproduction.
Sample 1

Related to Priority 1 Problem

  • Priority 2 Individuals who are: Age 60 and over in need of the following medically related trips: • Need for life sustaining medical care such as dialysis, chemotherapy, radiation treatment • Multi-system failure or conditions requiring immediate medical supervision/care, e.g. diabetes, heart disease, Chronic Obstructive Pulmonary Disease (COPD) • Surgery or non-elective (immediate need) procedure

  • Priority habitat means a habitat type with unique or significant value to one or more species. An area classified and mapped as priority habitat must have one or more of the following attributes:

  • Priority Non-Tax Claims means any Claim, other than an Administrative Claim or a Priority Tax Claim, entitled to priority in right of payment under section 507(a) of the Bankruptcy Code.

  • Priority Non-Tax Claim means any Claim other than an Administrative Expense Claim or a Priority Tax Claim, entitled to priority in payment as specified in section 507(a) of the Bankruptcy Code.

  • Priority area means the portions of the qualified incentive area

  • Priority species means species requiring protective measures and/or management guidelines to ensure their persistence at genetically viable population levels. Priority species are those that meet any of the criteria listed below.

  • Priority Claims means, collectively, Priority Tax Claims and Other Priority Claims.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Priority Tax Claim means any Claim of a Governmental Unit of the kind specified in section 507(a)(8) of the Bankruptcy Code.

  • Priority Claim means a Claim that is entitled to priority in payment pursuant to section 507(a) of the Bankruptcy Code that is not an Administrative Claim or a Priority Tax Claim.

  • Priority Tax Claims means Claims of governmental units of the kind specified in section 507(a)(8) of the Bankruptcy Code.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Severity 1 means the unavailability of multiple service resources and redundant capability is not available or has been exhausted.

  • Other Priority Claim means any Claim other than an Administrative Claim or a Priority Tax Claim entitled to priority in right of payment under section 507(a) of the Bankruptcy Code.

  • Severity 2 means the unavailability of an individual resource and redundant capability is not available or exhausted.

  • Other Priority Claims means any Claim, other than an Administrative Claim or a Priority Tax Claim, entitled to priority in right of payment under section 507(a) of the Bankruptcy Code.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for purposes of conducting safety surveillance and ongoing technical support of the Product.

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.